The awarding of the Lotus patent was highlighted today both two local news groups. Check out the full articles below! […]Read More
Boston Mountain Biotech
At Boston Mountain Biotech, we develop and patent technology that aids in the development of a new protein expression and purification platform. Currently this technology is being marketed through the Lotus® E. coli Cell Lines which demonstrate reduced host cell protein (HCP). These new reduced HCP bacterial cell lines simplify the development and manufacturing of recombinant protein therapeutics, vaccines and enzymes. At BMB, we are revolutionizing the pharmaceutical industry by providing protein purification solutions that result in new drugs moving from development to patient faster while simultaneously lowering the cost of manufacturing.
January 21, 2015